Browse all Canadian datasets
Browse the complete CanQuery catalogue, including downloadable files, live tables and maps.
Open datasets
- Parks, Recreation and Culture
- Drainage Utility
- Environment
- Transportation
- Traffic Signals
- 6 c 25 Lorentz.pdf
- 6 b 1888 Mountain.pdf
- 6 a Bulman Mountain.pdf
- 5 b 499 McLaughlin SD lotissment.pdf
- 5 a 517 McLaughlin SD Lotissement.pdf
- 4 b 150 Timberline.pdf
- PAC Agenda July 28 juillet 2021 lordre du jour CCU.pdf
- Methane Utility
- Survey Monuments
- Communications Utility
- Cadastral
- Sanitary Utility
- Water Utility
- Grid Areas of the Canada Oil and Gas Land Regulations
- Appearance before House Committee on National Defence – March 12 and April 6, 2021
- Appearance before House Committee on the Status of Women
- Put It On The Map!
- City of Coquitlam Imagery 2003
- Notice: Submission Filing Recommendations for Veterinary Drugs - Good Manufacturing Practices and Drug Establishment Licences
- Guidance on Veterinary Drug Joint Reviews
- Guidance Document: Master Files for Veterinary Products: Procedures and Administrative Requirements
- Guidance For Industry Management of Regulatory Submissions
- Guidance for Industry Preparation of Veterinary New Drug submissions
- Guidance for Industry - Preparation of Veterinary Abbreviated New Drug Submissions - Generic Drugs
- Guidance document on classification of veterinary drugs and livestock feeds
- Updated - Guidance Document: Preparation of Regulatory Activities in the "Non-eCTD Electronic-Only" Format
- Health Canada: Compilation of research abstracts 2019-2020
- Notice: Submission Filing Requirements - Good Manufacturing Practices (GMP)/Drug Establishment Licences (DEL)
- Deputy Minister for Women and Gender Equality's appearance at the House of Commons Standing Committee on the Status of Women (FEWO) (March 11, 2021)
- Minister for Women and Gender Equality's appearance at the House of Commons Standing Committee on the Status of Women (FEWO) (March 11, 2021)
- Appearance by the Honourable Steven Guilbeault before the Standing Committee on Canadian Heritage, study of Bill C-10, An Act to amend the Broadcasting Act and to make related and consequential amendments to other Acts
- Guidance Document: Tamper-resistance Formulations of Opioid Drug Products
- Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document
- Post-Notice of Compliance (NOC) Changes: Framework Document
- Guidance Document: Post-Notice of Compliance (NOC) Changes: Safety and Efficacy Document (for pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
- Guidance document: Post-Notice of Compliance (NOC) Changes: Framework Document (Pharmaceutical, biologic and radiopharmaceutical drugs for human use only)
- Post-Notice of Compliance (NOC) Changes – Quality Guidance
- Guidance Document: Determining Prescription Status for Human and Veterinary Drugs
- Guidance for Industry - Priority Review of Drug Submissions
- Guidance document: Product Monograph (2020)
- Guidance Document - Periodic Benefit-Risk Evaluation Report (PBRER) International Conference on Harmonisation (ICH) Topic E2C(R2)
- Notice - Adoption of the International Conference on Harmonisation (ICH) Guidance on Periodic Benefit Risk Evaluation Report - ICH Topic E2C(R2), as of March 1, 2013
- Health Product Vigilance Framework
- Guidance Document for Industry - Review of Drug Brand Names
- Notice to Stakeholders: Updates to the Opioid Patient Information Handout